- Home
- PDLB vs VNDA Comparison
PDLB vs VNDA Comparison
Compare PDLB & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDLB
- VNDA
- Stock Information
- Founded
- PDLB 1960
- VNDA 2002
- Country
- PDLB United States
- VNDA United States
- Employees
- PDLB N/A
- VNDA N/A
- Industry
- PDLB
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- PDLB
- VNDA Health Care
- Exchange
- PDLB Nasdaq
- VNDA Nasdaq
- Market Cap
- PDLB 302.8M
- VNDA 257.8M
- IPO Year
- PDLB 2017
- VNDA 2006
- Fundamental
- Price
- PDLB $12.81
- VNDA $4.43
- Analyst Decision
- PDLB
- VNDA Strong Buy
- Analyst Count
- PDLB 0
- VNDA 2
- Target Price
- PDLB N/A
- VNDA $16.50
- AVG Volume (30 Days)
- PDLB 47.1K
- VNDA 649.7K
- Earning Date
- PDLB 01-28-2025
- VNDA 02-13-2025
- Dividend Yield
- PDLB N/A
- VNDA N/A
- EPS Growth
- PDLB 212.14
- VNDA N/A
- EPS
- PDLB 0.46
- VNDA N/A
- Revenue
- PDLB $82,359,000.00
- VNDA $198,772,000.00
- Revenue This Year
- PDLB N/A
- VNDA $16.07
- Revenue Next Year
- PDLB $8.59
- VNDA $24.42
- P/E Ratio
- PDLB $27.85
- VNDA N/A
- Revenue Growth
- PDLB 10.53
- VNDA 3.18
- 52 Week Low
- PDLB $7.89
- VNDA $3.71
- 52 Week High
- PDLB $13.97
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- PDLB 38.25
- VNDA 44.53
- Support Level
- PDLB $13.29
- VNDA $4.34
- Resistance Level
- PDLB $13.60
- VNDA $4.65
- Average True Range (ATR)
- PDLB 0.24
- VNDA 0.21
- MACD
- PDLB -0.09
- VNDA -0.01
- Stochastic Oscillator
- PDLB 0.00
- VNDA 36.51
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.